Your browser doesn't support javascript.
loading
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.
Benotmane, Ilies; Risch, Simone; Doderer-Lang, Cécile; Caillard, Sophie; Fafi-Kremer, Samira.
Afiliação
  • Benotmane I; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Risch S; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
  • Doderer-Lang C; Fédération de Médecine Translationnelle (FMTS), Strasbourg, France.
  • Caillard S; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
  • Fafi-Kremer S; UR7292 Institute of Parasitology and Tropical Diseases of Strasbourg, Strasbourg University, Strasbourg, France.
Am J Transplant ; 21(8): 2871-2875, 2021 08.
Article em En | MEDLINE | ID: mdl-33961334
The exact duration of viable SARS-CoV-2 shedding in kidney transplant recipients (KTRs) remains unclear. Here, we retrospectively investigated this issue using cell cultures of SARS-CoV-2 RT-PCR-positive nasopharyngeal samples (n = 40) obtained from 16 KTRs with symptomatic COVID-19 up to 39 days from symptom onset. A length of viable SARS-CoV-2 shedding >3 weeks from the onset of symptoms was identified in four KTRs (25%). These results suggest that a significant proportion of KTRs can shed viable SARS-CoV-2 for at least 3 weeks, which may favor the emergence of new variants. Based on these data, we recommend prolonging the isolation of KTRs with COVID-19 until negative SARS-CoV-2 RT-PCR testing.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article